Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1. - Wikidata - wikimedia - TriplyDB

Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

http://www.wikidata.org/entity/Q39568285

about

The biological networks in studying cell signal transduction complexity: The examples of sperm capacitation and of endocannabinoid system.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death Transport of endocannabinoids across the plasma membrane and within the cell.Lipid rafts in neurodegeneration and neuroprotection.Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol.Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.

P2860

Q34417698-F3F5C497-B919-4D89-956B-8EB1543D2EE2 Q34700334-D82F51DE-FAE6-421A-9CD4-4B1D0B9B2A8C Q36176444-D029D6C8-3E2F-4F84-A588-022F568FA8DB Q37066018-4168741B-0516-4399-8DF2-1F0BF9142B97 Q37424055-00C2FE09-80EF-4FE3-95D5-A62F54BB81D4 Q38084704-682EC81B-78A6-4517-AD11-C19466AAAA38 Q38173298-E518114A-A14D-4B7F-AA6B-701CEAE8078F Q42872718-3504521D-3AF8-42B0-B8DE-090954AE1B07 Q42904836-224E12F6-DBB1-4C1E-ABA5-BA4968849B18

P2860

Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

http://www.wikidata.org/entity/Q39568285

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@en

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@nl

type

label

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@en

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@nl

prefLabel

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@en

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@nl

P1433

Q39568285-5B6CA24F-A359-41D5-B9F2-C5BC22778540

P1476

Q39568285-76BC95F0-B64C-4F86-9637-F312CF77A267

P2093

Q39568285-03209244-60F2-4D5A-AF8F-F9A311AB7053

Q39568285-2A8BBFC1-C259-4777-BA0F-B119B5E1EE02

Q39568285-4310A53B-2A1D-42BA-833C-9FAE078FA310

Q39568285-758EE60E-245D-4774-A9FB-823BE92F495C

Q39568285-BA5F1E1B-C6A8-4C2B-991D-F16DCBF0D267

Q39568285-C960724F-49F2-4DA8-8992-30518BBE9EFE

P2860

Q39568285-0321CE4D-0473-4B62-BF48-862AB9DAF924

Q39568285-0778CD84-B08F-41ED-8391-3E3D03358B37

Q39568285-0833DBD9-7690-483D-9F85-A7FE84E48606

Q39568285-09E91339-ECBC-426B-9138-41F216ABF9C3

Q39568285-0E1B5808-B9DD-44CF-9A36-C47B9FAF51D3

Q39568285-19CF0242-4616-4FD5-9493-0BD612ABE3A8

Q39568285-1BE4A57C-32B2-46AE-904C-2B4E8AEFB682

Q39568285-1EC0F4E9-D950-4122-8433-19A5A8329514

Q39568285-1F0C84AB-5E25-40A1-A8CC-522E81DE6972

Q39568285-20681A67-1465-468C-A393-E7B7931E34DE

P304

Q39568285-4B0C4F87-02C2-48DD-A418-CC45DB51B868

P31

Q39568285-3D9E5C6B-938D-4E3E-BFD6-2394F1BB11AE

P356

Q39568285-4D587005-3905-4AC3-A39D-BAEDE73285AB

P407

Q39568285-4007CE13-FD85-42A2-A86C-C28D07AD220B

P433

Q39568285-D1092BBE-9505-4FAE-A3F7-A16B67DB5D69

P478

Q39568285-260040AB-935E-498D-83EC-CBDC62F34144

P577

Q39568285-4D41C847-6814-43FB-B23B-0B856D8208D0

P5875

Q39568285-B2286E4A-25E1-4636-8079-7E8981F4C3FA

P698

Q39568285-411DEBFB-4D99-4724-8D21-DD3C48739111

P921

Q39568285-2D8C63E5-501A-4BC1-9534-E3AE42382C5D

Q39568285-515F8351-0D83-4046-9542-B3F9DBFFBC6A

P932

Q39568285-D7CFAE2D-16F5-450D-A531-1BDDFE3941FB

P356

J.1476-5381.2011.01380.X

P1433

British Journal of Pharmacology

P1476

Compartmentalization of endoca ...... ell line devoid of caveolin-1.

@en

P2093

Ana Juknat

http://www.w3.org/2001/XMLSchema#string

Ewa Kozela

http://www.w3.org/2001/XMLSchema#string

Heather B Bradshaw

http://www.w3.org/2001/XMLSchema#string

Neta Rimmerman

http://www.w3.org/2001/XMLSchema#string

Rivka Levy

http://www.w3.org/2001/XMLSchema#string

Zvi Vogel

http://www.w3.org/2001/XMLSchema#string

P2860

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

VIP21/caveolin is a cholesterol-binding protein

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

Receptors for acylethanolamides-GPR55 and GPR119

GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity

Identification of intracellular carriers for the endocannabinoid anandamide

A biosynthetic pathway for anandamide

Differential modulation of type 1 and type 2 cannabinoid receptors along the neuroimmune axis

Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

P304

2436-2449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01380.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50935529

http://www.w3.org/2001/XMLSchema#string

P698

21449981

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoids

P932

3423248

http://www.w3.org/2001/XMLSchema#string